245 related articles for article (PubMed ID: 23512663)
1. Intraoperative vancomycin pharmacokinetics in cardiac surgery with or without cardiopulmonary bypass.
Cotogni P; Passera R; Barbero C; Gariboldi A; Moscato D; Izzo G; Rinaldi M
Ann Pharmacother; 2013 Apr; 47(4):455-63. PubMed ID: 23512663
[TBL] [Abstract][Full Text] [Related]
2. Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.
Ferreira F; Santos S; Nascimento J; Strabelli T; Carmona M
Eur J Cardiothorac Surg; 2012 Aug; 42(2):300-5. PubMed ID: 22290920
[TBL] [Abstract][Full Text] [Related]
3. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations and pharmacokinetics of moxifloxacin in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.
Wiesner G; Martin K; Gertler R; Braun SL; Tassani P; Lange R; Gruber M
Int J Antimicrob Agents; 2013 May; 41(5):473-6. PubMed ID: 23481660
[TBL] [Abstract][Full Text] [Related]
5. Cefuroxime pharmacokinetics in pediatric cardiovascular surgery patients undergoing cardiopulmonary bypass.
Knoderer CA; Saft SA; Walker SG; Rodefeld MD; Turrentine MW; Brown JW; Healy DP; Sowinski KM
J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):425-30. PubMed ID: 20864357
[TBL] [Abstract][Full Text] [Related]
6. Endotoxemia in coronary artery bypass surgery: a comparison of the off-pump technique and conventional cardiopulmonary bypass.
Aydin NB; Gercekoglu H; Aksu B; Ozkul V; Sener T; Kiygil I; Turkoglu T; Cimen S; Babacan F; Demirtas M
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):843-8. PubMed ID: 12698147
[TBL] [Abstract][Full Text] [Related]
7. Impact of cardiopulmonary bypass on peripheral tissue metabolism and microvascular blood flow.
Mandak J; Pojar M; Cibicek N; Lonsky V; Palicka V; Kakrdova D; Nedvidkova J; Kubicek J; Zivny P
Perfusion; 2008 Nov; 23(6):339-46. PubMed ID: 19454562
[TBL] [Abstract][Full Text] [Related]
8. Alteration of vancomycin pharmacokinetics during cardiopulmonary bypass in patients undergoing cardiac surgery.
Ortega GM; Martí-Bonmatí E; Guevara SJ; Gómez IG
Am J Health Syst Pharm; 2003 Feb; 60(3):260-5. PubMed ID: 12613235
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin sequestration during cardiopulmonary bypass surgery.
Krivoy N; Yanovsky B; Kophit A; Zaher A; Bar-El Y; Adler Z; Gaitini L; Milo S
J Infect; 2002 Aug; 45(2):90-5. PubMed ID: 12217710
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous vancomycin in pediatric cardiopulmonary bypass surgery.
Hatzopoulos FK; Stile-Calligaro IL; Rodvold KA; Sullivan-Bolyai J; Del Nido P; Levitsky S
Pediatr Infect Dis J; 1993 Apr; 12(4):300-4. PubMed ID: 8483624
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin concentrations during cardiopulmonary bypass in pediatric cardiac surgery: a prospective study.
Ferrari F; Benegni S; Marinari E; Haiberger R; Garisto C; Rizza A; Giorni C; Quattrone MG; Arpicco S; Muntoni E; Milla P; Ricci Z
Perfusion; 2022 Sep; 37(6):553-561. PubMed ID: 33789546
[TBL] [Abstract][Full Text] [Related]
12. Effects of cardio-pulmonary bypass on vancomycin plasma concentration decay.
Miglioli PA; Merlo F; Grabocka E; Padrini R
Pharmacol Res; 1998 Oct; 38(4):275-8. PubMed ID: 9774490
[TBL] [Abstract][Full Text] [Related]
13. Does avoidance of cardiopulmonary bypass decrease the incidence of stroke in diabetics undergoing coronary surgery?
Abraham R; Karamanoukian HL; Jajkowski MR; von Fricken K; D'Ancona G; Bergsland J; Salerno TA
Heart Surg Forum; 2001; 4(2):135-40. PubMed ID: 11544620
[TBL] [Abstract][Full Text] [Related]
14. A single nucleotide polymorphism of macrophage migration inhibitory factor is related to inflammatory response in coronary bypass surgery using cardiopulmonary bypass.
Lehmann LE; Schroeder S; Hartmann W; Dewald O; Book M; Weber SU; Schewe JC; Stüber F
Eur J Cardiothorac Surg; 2006 Jul; 30(1):59-63. PubMed ID: 16527487
[TBL] [Abstract][Full Text] [Related]
15. Glycopeptide pharmacokinetics in current paediatric cardiac surgery practice.
Shime N; Kato Y; Kosaka T; Kokufu T; Yamagishi M; Fujita N
Eur J Cardiothorac Surg; 2007 Oct; 32(4):577-81. PubMed ID: 17689968
[TBL] [Abstract][Full Text] [Related]
16. Peripheral tissue metabolism during off-pump versus on-pump coronary artery bypass graft surgery: the microdialysis study.
Pojar M; Mand'ák J; Cibícek N; Lonský V; Dominik J; Palicka V; Kubícek J
Eur J Cardiothorac Surg; 2008 May; 33(5):899-905. PubMed ID: 18328724
[TBL] [Abstract][Full Text] [Related]
17. The effects of cardiopulmonary bypass on pulmonary function during robotic cardiac surgery.
Wang G; Xiao S; Gao C
Perfusion; 2015 Apr; 30(3):213-8. PubMed ID: 25784166
[TBL] [Abstract][Full Text] [Related]
18. Off-pump coronary artery bypass attenuates transient hepatocellular damage after myocardial revascularization.
Yamada T; Ochiai R; Takeda J; Kikuchi H; Ishibashi M; Watanabe K
J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):603-7. PubMed ID: 16202893
[TBL] [Abstract][Full Text] [Related]
19. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery.
Grassin-Delyle S; Couturier R; Abe E; Alvarez JC; Devillier P; Urien S
Anesthesiology; 2013 Apr; 118(4):853-62. PubMed ID: 23343649
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of post-cardiopulmonary bypass dosing of vancomycin in cardiac surgery.
Raikhelkar JK; Reich DL; Schure R; Varghese R; Bodian C; Scurlock C
Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):301-4. PubMed ID: 20841364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
